Cyclic 7-AA melanocortin agonist

PT-141 (Bremelanotide).

A cyclic 7-amino-acid heptapeptide melanocortin agonist with selectivity towards MC4R / MC3R relative to MC1R.

Key Information

CompoundPT-141 (Bremelanotide)
Research categoryMelanocortin Research
Available sizes10mg
PricingFrom £20
FormatLyophilised powder in sealed vial
Purity>99% by HPLC (Janoshik Analytical, batch-verified)
Intended useIn-vitro laboratory research only. Not for human consumption.

Chemical & Reference Data

Reference data drawn from public databases (PubChem, UniProt) and peer-reviewed literature. For research and laboratory characterisation only.

Compound classSynthetic 7-amino-acid α-MSH analogue (Bremelanotide)
Molecular formulaC50H68N14O10
Molecular weight1025.18 g/mol
CAS Registry Number189691-06-3
PubChem CID9941379
Number of residues7
Amino acid sequenceAc-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH
Receptor / mechanismMelanocortin receptor agonist (MC4R selective at relevant doses).
Reported half-lifeReported ~2.7 hours in human serum.
SolubilityLyophilised powder reconstitutes in bacteriostatic water for laboratory use.
Storage (lyophilised)Stable at 2–8 °C lyophilised for 24+ months.
Storage (reconstituted)Reconstituted: store at 2–8 °C, use within 14 days.
Clinical / regulatory statusApproved (Vyleesi) for research-relevant indications.

Research Profile

  • Cyclic heptapeptide α-MSH analogue
  • Melanocortin receptor agonist
  • MC4R activity profile
  • Third-party purity tested
  • Research use only

PT-141 (Bremelanotide) is a synthetic cyclic heptapeptide analogue of α-MSH, characterised in the literature for its activity at melanocortin receptors, particularly MC4R. Supplied as lyophilised powder for in-vitro research use only.

The above describes how this compound is characterised in the published peer-reviewed literature. It is not a claim about effects in humans.

Laboratory Handling

PT-141 (Bremelanotide) is supplied as a lyophilised (freeze-dried) powder in a sealed glass vial. For laboratory reconstitution, add the desired volume of diluent (typically bacteriostatic water) slowly down the side wall of the vial. Swirl gently until fully dissolved - do not vortex or shake. Store reconstituted solutions at 2–8 °C and use within 4–6 weeks.

Use our Reconstitution Volume Calculator to compute the resulting mg/ml concentration.

StateTemperatureShelf life
Lyophilised2–8 °C or −20 °CUp to 24 months
Reconstituted2–8 °C4–6 weeks typical

Purity & Verification

Every batch of PT-141 (Bremelanotide) we supply is independently HPLC-verified by Janoshik Analytical. Where a Janoshik report has been issued for the current batch it is supplied with the order and carries a unique verification key that can be authenticated against Janoshik's records. Reported purity is consistently above 99%.

Related Compounds

Researchers working with PT-141 (Bremelanotide) often work alongside the following compounds in the preclinical literature: